Government & Public Health Programs
Pharmacy Benefit Management
How will your organization transform to deliver greater value? We help implement process improvements, increase innovation and prepare for the future.
Innovative services and solutions to help your organization deliver coordinated, quality care and improved financial performance.
Government & Public Health Programs
How will you balance competing priorities and manage member volume? We help you adapt to the unexpected requirements the future may bring.
Pharmacy Benefit Management
Services include regulatory compliance solutions, clinical management programs, business intelligence systems and implementation advice.
Engage with our business and technology experts for strategic solutions that address the full scope of healthcare issues today, from compliance through integrated health management.
Cognizant’s Healthcare Business Consulting services address the industry trends and market forces that are driving business and IT spend—from rethinking new business models to optimizing operations and enabling technology innovation.Cognizant Health TranZform™
Deliver consumer‑centric care leveraging digital communications.
Cognizant offers solutions specific to the challenges of Healthcare organizations. Browse the pages below to learn more.
The Work Ahead: Mastering the Digital Economy
The Work Ahead is a research series providing insight and guidance on how business – and jobs – must evolve in an economy of algorithms, automation and AI.
Promotional References: Assembling Relevance, Ensuring Compliance, Avoiding Unnecessary Spend
Life sciences companies can avoid unnecessary risks and common sources of cost escalation by optimizing and centralizing the management of their promotional material references.
Ensuring Patient Safety & Beyond
ISO standards for identification of medical products (IDMP) are set to require pharmaceuticals companies to comply with medicinal identification standards. We explain how to get started and navigate a smooth IDMP transition.
The New CIO Mandate in Life Sciences
To lead digital transformation, CIOs at pharmaceutical and medical device companies need to adopt new workstyles and mindsets, including C-level relationship-building and the ability to both catalyze innovation and find the talent to execute on it.
In-Product Marketing: A Game-Changer for Customer-Minded Companies
In-product marketing programs are delivered directly to a customer's device or software application. Using an in-product marketing framework, software providers and players in several other industries can leverage the intrinsic value of products and customers, deepen their insights, and increase customer conversion and retention.
Identifying & Overcoming Gaps in the Specialty-Pharmacy Ecosystem
Specialty drug expenditures in the U.S. are rising dramatically, compelling manufacturers to accelerate the turnaround time from patient enrollment to drug disbursement. Using data analytics tools, these companies can track patients throughout their treatment and ensure continuous patient therapy.
Prescriptions for Healthcare's Digital CIOs
Healthcare CIOs are poised to expand their influence amid a perfect storm of regulatory and market forces that require a digital response. Our latest research reveals the new work styles and mindsets CIOs should adopt to prepare for this important organizational role.
How the Internet of Things Is Transforming Medical Devices
The Internet of Things (IoT) should be a central focus for medical device companies, as IoT dramatically expands and enhances the field for the entire stakeholder ecosystem. We offer a roadmap for medical devices companies seeking a wise and effective path forward with IoT.
Pegging Brand Performance Measures to the Metrics that Really Matter
To help enable pharmaceuticals companies to accurately evaluate brands, we offer a framework for determining the most relevant key performance indicators (KPIs) that take into account drug lifecycles, brand stage, geography, primary vs. secondary care and stakeholders.
Capitalizing on the ICD-10 Coding System: What Healthcare Organizations Need to Know
Having transitioned successfully to the ICD-10 coding system, healthcare organizations must now look beyond simply achieving compliance, and employ the system to identify and eliminate financial divergence, reduce revenue leaks, improve quality ratings, and drive competitive advantage.
A leading blues plan was preparing for Health Insurance Exchange (HIX) participation in several states and on the federal exchange. Cognizant was engaged to assist with organization change management and contingency planning efforts.
A centralized PMO was established to manage HIX functional projects and provide ongoing advisory services including:
To compete in the emerging ACO marketplace, a leading health system comprised of multiple hospitals, research centers and thousands of providers had begun to make risk-based contracts, pilot population-based care delivery programs and planning for exchange products. Cognizant and the health system partnered to determine a technology and business strategy including:
A national health insurance plan with more than 30 million members across the U.S. was under a corporate mandate to reduce medical management costs within the next fiscal year. The health plan’s clinical talent hiring and retention costs were high and it also faced considerable challenges in staffing for care management. The health plan needed a comprehensive strategy for addressing MLR regulations and compliance.
Cognizant developed a complete solution for handling the client’s commercial utilization management (UM) claims from pilot to roll-out. Our accredited and U.S. licensed clinical teams remotely accessed the client’s platform from multiple offshore operations centers and provided a full slate of UM services.
A leading hospital needed to determine the impact of ICD-10 transformation on their financial outlays; to identify any gaps in their program plan and understand potential risks that could impact overall ICD-10 transition. Cognizant was engaged to conduct an in-depth evaluation of the impact of ICD-10 on corporate finance and revenue cycle management functional areas, including: